Ricky Hopson has sold CTLT and made no open-market buys since Jul 2021
Pres BioProduct Delivery, CoS at Catalent, Inc.
SEC CIK 0001862832 · Filings on SEC.gov ↗
$0Bought
$1.1MSold
NoneLast buy
Every filing
9 filings since Jul 2021, newest first
CTLTSell
Catalent, Inc.
Pres BioProduct Delivery, CoS
$39K−2.0%Aug 5
CTLTSell
Catalent, Inc.
Pres BioProduct Delivery, CoS
$76K−6.0%Jun 5
CTLTSell
Catalent, Inc.
Pres Clinical Dev Supply Div
$32K−4.0%Jan 25
CTLTSell
Catalent, Inc.
Pres Clinical Dev Supply Div
$199K−11.0%Sep 2
CTLTSell
Catalent, Inc.
Pres Clinical Dev Supply Div
$156K−7.0%Aug 26
CTLTSell
Catalent, Inc.
Pres, Clinical Dev, Supply
$97K−5.0%Jul 28
CTLTSell
Catalent, Inc.
VP and Chief Accounting Officer
$240K−12.0%Feb 1
CTLTSell
Catalent, Inc.
VP and Chief Accounting Officer
$193K−7.0%Aug 30
CTLTSell
Catalent, Inc.
VP and Chief Accounting Officer
$41K−2.0%Jul 28
Filings come from SEC EDGAR. Not investment advice.